WORLDCARE CLINICAL COMMENCES INDEPENDENT REVIEW OF LARGE PHASE III MELANOMA TRIAL

WORLDCARE CLINICAL COMMENCES INDEPENDENT REVIEW OF LARGE PHASE III MELANOMA TRIAL

Boston, MA, March 15, 2021 — WorldCare Clinical (WCC), a leading provider of imaging services in Oncology clinical trials, today announced that it had commenced radiology, dermatology, and oncology central review services on a Phase III international clinical trial to assess a new …

Leave a Reply